Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepagina
  2. Aandelen
  3. BelgiŽ
  4. Euronext Bruxelles
  5. Sequana Medical N.V.
  6. Nieuws
  7. Andere talen
    SEQUA   BE0974340722

SEQUANA MEDICAL N.V.

(SEQUA)
  Rapport
Real Time Euronext Bruxelles  -  15:52 23-09-2022
5.300 EUR   -3.28%
09/09WEEKOVERZICHT : Bel20 omhoog
AM
09/09Sequana Medical NV rapporteert winstresultaten voor het halfjaar dat eindigde op 30 juni 2022
CI
08/09Bel20 in het groen naar rentebesluit ECB
AM
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuwsAnalyse MarketScreener
Nieuws in andere talen op SEQUANA MEDICAL N.V.
09/09Sequana Medical NV Reports Earnings Results for the Half Year Ended June 30, 2022
08/09TRANSCRIPT : Sequana Medical NV, H1 2022 Earnings Call, Sep 08, 2022
08/09SEQUANA MEDICAL N : announces H1 2022 results and provides business update
25/08SEQUANA MEDICAL N : Alexandra Clyde appointed to Sequana Medical Board of Directors
25/08Sequana Medical NV Announces Board Changes
20/07Company's cash runway extended into Q3 2023
20/07SEQUANA MEDICAL N : secures EUR 10 million loan facility with Kreos Capital
20/07Sequana Medical NV Secures EUR 10 Million Loan Facility with Kreos Capital
20/07Sequana Medical NV announced that it has received €10 million in funding from Kreo..
19/07TRANSCRIPT : Sequana Medical NV - Special Call
19/07Sequana Medical NV Appoints Doug Kohrs as an Independent Non-Executive Director of the ..
19/07Doug Kohrs appointed to Sequana Medical Board of Directors; Highly experienced US medte..
19/07SEQUANA MEDICAL N : completes enrollment in Phase 2a SAHARA I DSR study, reports disease-m..
19/07SEQUANA MEDICAL N : Doug Kohrs appointed to Sequana Medical Board of Directors
19/07Sequana Medical Completes Enrollment in Phase 2a SAHARA I DSR, Reports Disease-Modifyin..
27/05Sequana Medical announces results of Annual and Extraordinary General Meetings of Share..
27/04SEQUANA MEDICAL N : Remuneration Policy
27/04SEQUANA MEDICAL N : announces Annual and Extraordinary General Meetings of Shareholders on..
27/04SEQUANA MEDICAL N : Statutory annual accounts for the year ended 31 December 2021
27/04SEQUANA MEDICAL N : Statutory auditor's report on the consolidated accounts for the year e..
27/04SEQUANA MEDICAL N : Statutory auditor's report on the annual accounts for the year ended 3..
27/04SEQUANA MEDICAL N : Statutory auditor's report on the Bootstrap Warrants
27/04SEQUANA MEDICAL N : Report of the Board of Directors on the annual accounts for the year e..
27/04SEQUANA MEDICAL N : Report of the Board of Directors on the Bootstrap Warrants
27/04Sequana Medical NV Auditor Raises 'Going Concern' Doubt
12/04TRANSCRIPT : Sequana Medical NV, 2021 Earnings Call, Apr 12, 2022
12/04Sequana Medical announces 2021 Full Year Results and 2022 Outlook
12/04Sequana Medical NV Reports Earnings Results for the Full Year Ended December 31, 2021
08/04Sequana Medical to present at Needham's Healthcare Conference and attend Kempen's Life ..
08/04Sequana Medical to present at Needham's Healthcare Conference and attend Kempen's Life ..
05/04Sequana Medical Announces the Completion of alfapump Implantations in POSEIDON, the Nor..
05/04Sequana Medical Announces the Completion of Alfapump Implantations in Poseidon, the Nor..
31/03Sequana Medical Notice of 2021 Full Year Results and Business Update
28/03Transparency Notifications from Shareholders
18/03Transparency Notifications from Shareholders
10/03Sequana Medical Announces New Share Capital Amount and New Number of Shares
09/03Sequana Medical to Present at BioCapital Europe and Oppenheimer's Annual Healthcare Con..
09/03Sequana Medical to Present at BioCapital Europe and Oppenheimer's Annual Healthcare Con..
14/02Sequana Medical receives certification under MDR, the new European Medical Device Regul..
14/02Sequana Medical Receives Certification Under MDR,†the New European Medical Device Regul..
14/02Sequana Medical NV Receives Certification Under Mdr, the New European Medical Device Re..
14/02SEQUANA MEDICAL N : receives certification under MDR, the new European Medical Device Regu..
03/02SEQUANA MEDICAL N : to present at BTIG MedTech, Digital Health, Life Science & Diagnostic ..
24/01SEQUANA MEDICAL N : Announces new share capital amount and new number of shares
2021SEQUANA MEDICAL N : to attend 11th Annual LifeSci Partners Corporate Access Event and H.C...
2021TRANSCRIPT : Sequana Medical NV - Special Call
2021Sequana Medical Announces Positive Interim Results of SAHARA DESERT
2021SEQUANA MEDICAL N : announces positive interim results of SAHARA DESERT, the alfapump DSRģ..
2021Sequana Medical NV Announces the Completion of Patient Enrolment in Poseidon, the North..
2021SEQUANA MEDICAL N : announces the completion of patient enrolment in POSEIDON, the North A..
2021Sequana Medical to present at Jefferies London Healthcare Conference
2021Sequana Medical Gets UK Certification For Quality Management System
2021Sequana Medical NV Receives MDSAP Certification and Expands Its Quality Management Syst..
2021Sequana Medical receives MDSAP certification and expands its Quality Management System ..
2021Innovators in the treatment of diuretic-resistant fluid overload
2021Sequana Medical Announces FDA Approval to Expand Patient Enrolment in North American Pi..
2021TRANSCRIPT : Sequana Medical NV, H1 2021 Earnings Call, Sep 02, 2021
2021SEQUANA MEDICAL N : announces H1 2021 results and provides business update
2021Sequana Medical NV Announces Consolidated Earnings Results for the Six Months Ended Jun..
2021SEQUANA MEDICAL N : Appoints Jackie Fielding, Former Medtronic VP,†to its Board of Directo..
2021Sequana Medical NV Appoints Jackie Fielding †to its Board of Directors, Effective as of..
2021SEQUANA MEDICAL N : Notice of 2021 Half Year Results and Business Update
2021Sequana Medical’s Results from RED DESERT Alfapump DSRģ Study Presented as One of the H..
2021TRANSCRIPT : Sequana Medical NV - Special Call
2021SEQUANA MEDICAL N : Announces Positive Results From Second Interim Analysis of North Ameri..
2021Sequana Medical Announces Positive Results From Second Interim Analysis of North Americ..
2021Sequana Medical NV Auditor Raises 'Going Concern' Doubt
2021Sequana Medical to Host a Key Opinion Leader Webinar on “The Impact of Liver Asci..
2021Results From Sequana Medical's RED DESERT alfapump DSRģ Study Selected for Presentation..
2021SEQUANA MEDICAL N : Announces First Patient Enrolled in SAHARA DESERT
2021Sequana Medical Announces First Patient Enrolled in SAHARA DESERT
2021TRANSCRIPT : Sequana Medical NV - Special Call
2021Sequana Medical Announces Strong Top-Line Results from RED DESERT alfapump DSRģ Study a..
2021Sequana Medical NV Announces Positive Top-Line Results from the Red Desert Study with R..
2021Sequana Medical Announces Annual and Extraordinary General Meetings of Shareholders on ..
2021SEQUANA MEDICAL N : Announces new share capital amount and new number of shares
2021TRANSCRIPT : Sequana Medical NV, 2020 Earnings Call, Mar 17, 2021
2021Sequana Medical Announces 2020 Full Year Results and 2021 Outlook
2021Sequana Medical NV Reports Consolidated Earnings Results for the Year Ended December 31..
2021Sequana Medical Notice of 2020 Full Year Results and Business Update
2021Sequana Medical's New Share Capital Amount and New Number of Shares
2021SEQUANA MEDICAL N : New share capital amount and new number of shares
2021SEQUANA MEDICAL N : announces February-March 2021 Investor Conference Schedule
2021SEQUANA MEDICAL N : announces granting of key alfapump DSRģ patents in U.S. and Europe
2020SEQUANA MEDICAL : announces January 2021 Investor Conference Schedule
2020TRANSCRIPT : Sequana Medical NV - Special Call
2020Sequana Medical to Host KOL Event on “The Challenge of Diuretic Resistance in the..
2020TRANSCRIPT : Sequana Medical NV - Special Call
2020SEQUANA MEDICAL : Announces Positive Interim Data From North American Pivotal alfapumpģ St..
2020Sequana Medical Announces Positive Interim Data From North American Pivotal alfapumpģ S..
2020Sequana Medical Announces Positive Interim Data from North American Pivotal Alfapumpģ S..
2020SEQUANA MEDICAL : announces positive interim data from North American pivotal alfapumpģ st..
2020SEQUANA MEDICAL : to present at Jefferies 2020 Virtual London Healthcare Conference
2020Sequana Medical to present at Jefferies 2020 Virtual London Healthcare Conference
2020SEQUANA MEDICAL : to present at Jefferies 2020 Virtual London Healthcare Conference
2020TRANSCRIPT : Sequana Medical NV - Special Call
2020SEQUANA MEDICAL : announces strong interim results from RED DESERT alfapumpģ DSR study and..
2020SEQUANA MEDICAL : Announces Strong Interim Results From RED DESERT alfapumpģ DSR Study and..
2020Sequana Medical Announces Strong Interim Results From RED DESERT alfapumpģ DSR Study an..
2020Sequana Medical Announces Strong Interim Results from RED DESERT alfapumpģ DSR Study an..
Volgende evenement op SEQUANA MEDICAL N.V.